Learn more about lung cancer at http://www.YouAndLungCancer.com
Christi shares about her lung cancer diagnosis journey and the initial treatments she received. Later when it was discovered that her lung cancer had progressed to stage 4, she had comprehensive biomarker testing which revealed she has the EGFR exon 19 deletion lung cancer mutation. It is recommended that biomarker testing happen immediately following diagnosis to determine the best treatment for each patient's unique cancer.